RBF Capital’s Zimmer Biomet ZBH Stock Holding History

RBF Capital’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-4,017	Closed	-$531K	–	411
2020 Q3	$531K	Hold	4,017	–	–	0.05%	235
2020 Q2	$466K	Buy	+4,017	New	+$463K	0.05%	248

Other funds holding ZBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

RBF Capital's ZBH Position: Q4 2020 in Review

RBF Capital sold out of Zimmer Biomet (ZBH) in Q4 2020, closing a stake of 4,017 shares — an estimated $531K sold.

RBF Capital first reported a position in ZBH in Q2 2020 and held it in 2 quarters. The position peaked at $531K in Q3 2020. 1,011 funds tracked by Wall St. Rank hold ZBH as of Q4 2020.

RBF Capital reported no remaining Zimmer Biomet position as of Q4 2020 after selling out during the quarter.
RBF Capital sold 4,017 Zimmer Biomet shares in Q4 2020, an estimated $531K.
RBF Capital first reported a position in Zimmer Biomet in Q2 2020 and held it in 2 quarters.
RBF Capital's Zimmer Biomet position peaked at $531K in Q3 2020.
1,011 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2020.

Based on RBF Capital's 13F filing for Q4 2020, filed 11 Feb 2021.